Zacks Investment Research Downgrades Maximus Inc. (MMS) to Sell
Maximus Inc. (NYSE:MMS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Wednesday.
According to Zacks, “MAXIMUS, Inc. is an extremely dynamic and complex organization that offers government and industry a range of unique services, products, and solutions. The diverse services and products that MAXIMUS offers may be categorized into three groups: Government Program Management and Operations, Consulting, and Systems. Government Program Management and Operations focuses on having a measurable impact on the lives of the citizens we help government serve. The insights of MAXIMUS Consulting, and the technological innovations advanced through Systems, help government gain program efficiencies and pursue improvements that in turn benefit citizens. “
Several other analysts also recently commented on the stock. Maxim Group lifted their target price on shares of Maximus from $71.00 to $74.00 and gave the stock a “buy” rating in a report on Thursday, August 4th. KeyCorp began coverage on shares of Maximus in a report on Monday, July 11th. They set a “buy” rating for the company. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $63.00.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/08/zacks-investment-research-downgrades-maximus-inc-mms-to-sell.html
Shares of Maximus (NYSE:MMS) traded down 0.91% during mid-day trading on Wednesday, reaching $54.60. 468,431 shares of the company’s stock traded hands. Maximus has a 12 month low of $45.15 and a 12 month high of $69.85. The stock has a market cap of $3.54 billion, a PE ratio of 22.31 and a beta of 1.15. The firm has a 50 day moving average price of $57.40 and a 200-day moving average price of $55.79.
Maximus (NYSE:MMS) last announced its earnings results on Thursday, August 4th. The company reported $0.75 EPS for the quarter, topping the consensus estimate of $0.71 by $0.04. The business earned $617.10 million during the quarter, compared to the consensus estimate of $625.62 million. Maximus had a net margin of 6.91% and a return on equity of 23.89%. Maximus’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.62 EPS. On average, analysts predict that Maximus will post $2.65 earnings per share for the current fiscal year.
In other news, Director Raymond B. Ruddy sold 18,000 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $60.00, for a total value of $1,080,000.00. Following the completion of the transaction, the director now directly owns 295,552 shares in the company, valued at approximately $17,733,120. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, President Bruce Caswell sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, September 22nd. The shares were sold at an average price of $56.99, for a total transaction of $1,139,800.00. Following the completion of the transaction, the president now owns 36,386 shares of the company’s stock, valued at $2,073,638.14. The disclosure for this sale can be found here. 3.60% of the stock is currently owned by insiders.
Institutional investors have recently modified their holdings of the stock. Navellier & Associates Inc purchased a new position in shares of Maximus during the second quarter valued at approximately $208,000. Massmutual Trust Co. FSB ADV boosted its position in shares of Maximus by 3.6% in the first quarter. Massmutual Trust Co. FSB ADV now owns 3,879 shares of the company’s stock valued at $204,000 after buying an additional 134 shares during the last quarter. Parametrica Management Ltd purchased a new position in shares of Maximus during the second quarter valued at approximately $216,000. LS Investment Advisors LLC boosted its position in shares of Maximus by 70.9% in the second quarter. LS Investment Advisors LLC now owns 3,928 shares of the company’s stock valued at $217,000 after buying an additional 1,630 shares during the last quarter. Finally, BW Gestao de Investimentos Ltda. boosted its position in shares of Maximus by 28.6% in the second quarter. BW Gestao de Investimentos Ltda. now owns 4,994 shares of the company’s stock valued at $277,000 after buying an additional 1,110 shares during the last quarter. Institutional investors own 99.00% of the company’s stock.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.